Carter Ledyard client Trinity Biotech Plc acquired Immco Diagnostics Inc. (Immco) on July 26, 2013 for a consideration of $32.75m. Headquartered in Buffalo, New York, and employing 90 people, Immco is a diagnostic company specializing in the development, manufacture and sale of autoimmune test kits on a worldwide basis. This product line is complemented by specialized reference laboratory services in diagnostic immunology, pathology and immunogenetics, marketed to U.S.-based reference laboratories and hospitals.
CL&M attorneys Alan J. Bernstein, Howard J. Barnet, Jr., Patricia Matzye, Bryan J. Hall, Natalie F. Wilmore and Katherine A. Mirett represented Trinity Biotech Plc in this transaction.